GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

Jaume Mora,Alicia Castañeda,Sara Perez-Jaume,Antonio Lopez-Pousa,E. Maradiegue,Claudia Valverde,J Martin-Broto,X. Garcia del Muro,Ofelia Cruz,Julia Cruz,Javier Martínez Trufero,J. Maurel,Maria Angeles Vaz,E. de Álava,C. de Torres

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

2017

Jaume Mora
Alicia Castañeda
Sara Perez-Jaume
Antonio Lopez-Pousa
E. Maradiegue
Claudia Valverde
J Martin-Broto
X. Garcia del Muro
Ofelia Cruz
Julia Cruz
Javier Martínez Trufero
J. Maurel
Maria Angeles Vaz
E. de Álava
C. de Torres

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

Keywords:

Medicine
Pathology
Sarcoma
Phases of clinical research
Chemotherapy
Gemcitabine
Docetaxel
intensive chemotherapy
Internal medicine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations